Individuals taking Dasatinib, a different anti-cancer agent that restricts antigen-driven and homeostatic proliferation of CD4+ T cells in PWH59, also appeared to have lower HIV DNA levels than those taking ART alone, but whether this effect is driven by anti-proliferation requires more research60. The gene discussed is CD4; the disease is cancer.